Li Dong
8Patents
2h-index
62Co-inventors
50Inventor score
Filing activity: Dec 14, 2001 → Apr 4, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8927559B2 | Quinazolinone-type compounds as CRTH2 antagonists | Chemistry; Metallurgy | 4 | Active |
| US8592383B2 | Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators | Chemistry; Metallurgy | 4 | Active |
| US9469615B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US8569312B2 | Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US7081561B2 | Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof | Physics | 0 | Expired |
| US8497271B2 | Modulators of G protein-coupled receptor 88 | Chemistry; Metallurgy | 0 | Active |
| US8476274B2 | Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US8324213B2 | Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.